Will AI revolutionize drug development? Researchers explain why it depends on how it’s used
Researchers have applied AI to every step of the drug development process. But this might not be enough to design safe and ...
technologynetworks6d
Exploring the Frontiers of Pharmaceutical Innovation
In this interview, we explore the key changes shaping the pharmaceutical industry, maintaining compliance across global ...
GEN13d
Unlocking the Potential of Ketones and Esters Could Streamline Drug Development
Scripps Research chemists unlock the potential of ketone and ester molecules, paving the way for greener and more efficient ...
AI can call the shots on drug making because it 'doesn't have a career at stake,' major pharma CEO says
AI can call the shots on drug making because it 'doesn't have a career at stake,' major pharma CEO says Sanofi's CEO said the ...
Why Drug Developers That Utilize AI, Including SDGR and RXRX, Are Jumping
Pharmaceutical firms that specialize in utilizing AI to speed up the drug discovery process are soaring today.
Business Wire12d
Simulations Plus Supported Development of Majority of FDA-Approved Drugs in 2024
This achievement underscores the increasing role that innovative technologies and collaborative expertise plays in ...
manilatimes4d
Pliant Therapeutics Appoints Delphine Imbert, Ph.D. as Chief Technical Officer
Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage biotechnology company and leader in the discovery and development of ...
Hallucinations in AI: How GSK is addressing a critical problem in drug development
Hallucinations are a persistent problem in healthcare. Here's how GSK is using test-time compute scaling to improve its gen AI systems.
Business Insider5d
AI can call the shots on drug making because it 'doesn't have a career at stake,' major pharma CEO says
That process is when manufacturers figure out what compounds should qualify as candidates for new medicines. The pharmaceutical company, which makes drugs like Lantus insulin jabs and Plavix blood ...